Cognition Therapeutics Receives Extension to Meet Nasdaq Minimum Bid Price Requirement for Continued Listing: Company Details

Cognition Therapeutics Receives Notice from Nasdaq: What Does This Mean for the Company and the Investors? On September 12, 2024, Cognition Therapeutics, Inc. (CGTX) received a notification from the Nasdaq Stock Market LLC that the bid price of its common stock had closed below $1.00 per share for 30 consecutive business days. This triggered a…

Read More

“Act Now: Protect Your Investment – Important Deadline Approaching for Symbotic Inc. Investors”

Symbotic Inc. Securities Class Action Lead Plaintiff Deadline Reminder NEW YORK, Feb. 02, 2025 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Symbotic Inc. (NASDAQ: SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025…

Read More

“From Securities Lawyer to Movie Critic: Ripple Executive Jokes About Career Change”

Ripple Executives Mock Demoted SEC Lawyer The Controversy Unfolds Recently, Ripple executives have found themselves in hot water after mocking Jorge Tenreiro, the demoted lawyer of the U.S. Securities and Exchange Commission (SEC) who was leading the agency’s crypto enforcement efforts. The incident took place during a private meeting where the executives made disparaging remarks…

Read More

“Unveiling the Success of Gentex Corporation: A Comprehensive Recap of the Q4 2024 Earnings Call”

Gentex Corporation (NASDAQ:GNTX) Q4 2024 Earnings Conference Call Company Participants: Josh O’Berski – Director of Investor Relations Steve Downing – President and Chief Executive Officer Neil Boehm – Chief Operations Officer and Chief Technology Officer Kevin Nash – Chief Financial Officer, CAO, Vice President of Finance, and Treasurer Conference Call Participants: Luke Junk – Baird…

Read More